World-first tooth regrowth drug to begin human trials in September 2024
New Atlas - 28-May-2024Drug has shown promising results in animals, offering hope for those with tooth loss
Join the club for FREE to access the whole archive and other member benefits.
Public Research university.
Since its foundation in 1897, Kyoto University has worked to cultivate academic freedom under a spirit of self-reliance and self-respect, and to open up new horizons in creative scholarly endeavor. The university has also sought to contribute to peaceful coexistence across the global community.
Our world is currently experiencing a number of rapid changes that would have been unimaginable in the 20th century. The global conflict structure, which was expected to be resolved with the end of the Cold War, is actually growing in both complexity and intensity as a result of ethnic and religious tensions. At the same time, the pace of global environmental degradation accelerates, unprecedented major disasters and deadly infectious diseases wreak havoc across the world, and financial crises shake both national economies and individual lives to the very core. Universities need to think seriously about what they stand for in these turbulent times.
Visit website: https://www.kyoto-u.ac.jp/en/
%E4%BA%AC%E9%83%BD%E5%A4%A7%E5%AD%A6
Details last updated 23-Nov-2019
Professor at Kyoto University and Director of the National Center for Geriatrics and Gerontology (NCGG)
Professor, Nobel prize winner and stem cell researcher, Senior scientific advisor to Altos Labs
Drug has shown promising results in animals, offering hope for those with tooth loss
Promising tooth development approach for tooth anomalies after successful trials on pigs & dogs
A man in his 50s is the first of seven patients to receive the experimental therapy
Implantation of induced stem cells in brains with Parkinson’s disease is showing promising results in monkeys
There is a risk of developing brain tumours according to some experts
New stem cell treatment for Parkinson's entered the human trial stage in August
Will produce cells derived from iPS cells for commercial applications. Existing iPSC production ...